TAG:
laboratory companies
Sonic Lands in New York with Sunrise Purchase
By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue
CEO SUMMARY: Sonic Healthcare Limited of Sydney, Australia, continues to open its checkbook and purchase independent laboratory companies here in the United States. The latest deal is its agreement to purchase Sunrise Medical Laboratories of Hauppauge, New York, for as much as $168 millio…
Exclusive Lab Contracts Have Consequences
By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue
CEO SUMMARY: During the past seven months, competition in the Northeast has intensified. Decisions by UnitedHealth and Aetna to exclude a national laboratory from their respective provider panels has forced many physicians to reconsider their choice of laboratory provider—creating an op…
Lakewood Pathology Changes Leadership
By Robert Michel | From the Volume XIV No. 10 – July 16, 2007 Issue
CEO SUMMARY: Following the arrival of a new majority owner and a capital commitment of $50 million last year, Lakewood Pathology Associates has taken additional steps to pursue growth. Lakewood plans to acquire small to mid-sized companies that are complementary to its position in the ana…
LabCorp Buys Hospital Outreach Lab in Florida
By Robert Michel | From the Volume XIV No. 9 – June 25, 2007 Issue
CEO SUMMARY: Once again, a national laboratory has seized the opportunity to acquire a strong regional laboratory. This time it’s the sale of DSI Laboratories, Inc., of Naples, Florida, to Laboratory Corporation of America. DSI’s owner is NCH Healthcare System, which owns two hospital…
Global Laboratory Trends Dominated by Rising Costs and Labor Shortage
By Robert Michel | From the Volume XIV No. 9 – June 25, 2007 Issue
“The Web has transformed many industries and it’s clearly affected our industry. This trend will help raise the bar in quality and overall performance among laboratories and manufacturers.” —Jim Reid-Anderson Chairman, President, and CEO of Dade Behring…
Quest Wants It Both Ways with Payer Contracts
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: Once again, public laboratory companies are pursuing short-term strategies that promise competitive advantage to themselves. But these strategies also carry long term risks that could burden the entire laboratory industry. Contradictions in the current cycle of competition fo…
Inverness Buys Biosite, Has New Venture with P&G
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: On the same day that Inverness Medical Innovations announced that it would acquire Biosite, thus beating out Beckman Coulter in the bidding war for Biosite, Inverness also announced that it had entered into a joint venture with Procter & Gamble. Together, the two companie…
LabCorp & Sunrise CEOs Score at Exec War College
By Robert Michel | From the Volume XIV No. 7 – May 14, 2007 Issue
CEO SUMMARY: This year’s Executive War College on Lab and Pathology Management delivered major surprises, along with first news of breakthrough innovations and emerging trends. Managed care contracting for lab testing services was this year’s premier topic and there was keen interest …
Quest Diagnostics Regains Contract to Manage British Hospital Lab
By Robert Michel | From the Volume XIV No. 7 – May 14, 2007 Issue
HAVING DECLARED IN JANUARY THAT IT WANTED TO EXPAND OVERSEAS, Quest Diagnostics Incorporated announced on March 22 that it had been awarded a five-year contract to provide laboratory services to a hospital trust and primary care trust in London, England. Quest Diagnostics will provi…
Quest Bites: Will Pay $2 Billion for AmeriPath
By Robert Michel | From the Volume XIV No. 6 – April 23, 2007 Issue
CEO SUMMARY: From its inception in the mid-1990s as a pathology physician practice management (PPM) company, AmeriPath was a business that its investors created specifically to be sold. Now Quest Diagnostics Incorporated is stepping up to pay a princely ransom of $2 billion to make AmeriP…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized